Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline
View/ Open
Volume
29
Pagination
G1 - G33
DOI
10.1530/ERC-22-0035
Journal
ENDOCRINE-RELATED CANCER
Issue
ISSN
1351-0088
Metadata
Show full item recordAuthors
Howard, SR; Freeston, S; Harrison, B; Izatt, L; Natu, S; Newbold, K; Pomplun, S; Spoudeas, HA; Wilne, S; Kurzawinski, TRCollections
- Centre for Endocrinology [560]
Licence information
Copyright statements
Related items
Showing items related by title, author, creator and subject.
-
Targeting Thyroid Stimulating Hormone Receptors in Radioiodine Resistant Dedifferentiated Thyroid Cancer
Boshoff, Ana Sousa Marcelino (Queen Mary University of London, 2012)The most common type of thyroid cancer, differentiated thyroid cancer (DTC), is diagnosed by radioactive iodine whole body scanning (WBS) and treated with radiotherapy using iodine-131 (131I). The success of this ... -
Impact of thyroiditis on I-131 uptake during ablative therapy for differentiated thyroid cancer
Lim, ES; Shah, SG; Waterhouse, M; Akker, S; Drake, W; Plowman, N; Berney, DM; Richards, P; Adams, A; Nowosinska, E (2019-05) -
Thyrotropin releasing hormone and its cyclised C-terminal peptide inhibit thyroglobulin release from thyroid follicular cells: evidence for acute regulation of hormone production at the thyroid gland
Sun, D; Garcia, E; The, CS; Raja, U; Kindt, L; Collis, DWP; Azevedo, HS; Korbonits, M; Ghilchik, M; King, PJ